Home NDC 0781-1818 Furosemide
Product NDC 0781-1818
11-digit product format 007811818
Labeler code 0781
Product ID 0781-1818_12fb3c44-a007-44ac-824c-e55d5af4b998
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Furosemide
Dosage form TABLET
Route ORAL
Labeler Sandoz Inc
Application NDA018569
Marketing category NDA
Marketing start 1981-10-19
Marketing end 2020-11-30
Substance FUROSEMIDE
Active strength 20 mg/1
Pharmacologic classes Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC]
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 48 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N018569-001 FUROSEMIDE FUROSEMIDE 40MG TABLET / ORAL AB Approved before 1982 N018569-002 FUROSEMIDE FUROSEMIDE 20MG TABLET / ORAL AB Approved before 1982 N018569-005 FUROSEMIDE FUROSEMIDE 80MG TABLET / ORAL AB 1984-08-14
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 123 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N018569-001 FUROSEMIDE 40MG TABLET / ORAL AB Approved before 1982 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N018569-002 FUROSEMIDE 20MG TABLET / ORAL AB Approved before 1982 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N018569-005 FUROSEMIDE 80MG TABLET / ORAL AB 1984-08-14 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N018569-001 FUROSEMIDE 40MG TABLET / ORAL AB Approved before 1982 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N018569-002 FUROSEMIDE 20MG TABLET / ORAL AB Approved before 1982 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N018569-005 FUROSEMIDE 80MG TABLET / ORAL AB 1984-08-14 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N018569-001 FUROSEMIDE 40MG TABLET / ORAL AB Approved before 1982 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N018569-002 FUROSEMIDE 20MG TABLET / ORAL AB Approved before 1982 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N018569-005 FUROSEMIDE 80MG TABLET / ORAL AB 1984-08-14 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N018569-001 FUROSEMIDE 40MG TABLET / ORAL AB Approved before 1982 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N018569-002 FUROSEMIDE 20MG TABLET / ORAL AB Approved before 1982 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N018569-005 FUROSEMIDE 80MG TABLET / ORAL AB 1984-08-14 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N018569-001 FUROSEMIDE 40MG TABLET / ORAL AB Approved before 1982 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N018569-002 FUROSEMIDE 20MG TABLET / ORAL AB Approved before 1982 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N018569-005 FUROSEMIDE 80MG TABLET / ORAL AB 1984-08-14 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N018569-001 FUROSEMIDE 40MG TABLET / ORAL AB Approved before 1982 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N018569-002 FUROSEMIDE 20MG TABLET / ORAL AB Approved before 1982 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N018569-005 FUROSEMIDE 80MG TABLET / ORAL AB 1984-08-14 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N018569-001 FUROSEMIDE 40MG TABLET / ORAL AB Approved before 1982 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N018569-002 FUROSEMIDE 20MG TABLET / ORAL AB Approved before 1982 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N018569-005 FUROSEMIDE 80MG TABLET / ORAL AB 1984-08-14 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N018569-001 FUROSEMIDE 40MG TABLET / ORAL AB Approved before 1982 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N018569-002 FUROSEMIDE 20MG TABLET / ORAL AB Approved before 1982 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N018569-005 FUROSEMIDE 80MG TABLET / ORAL AB 1984-08-14 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N018569-001 FUROSEMIDE 40MG TABLET / ORAL AB Approved before 1982 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N018569-002 FUROSEMIDE 20MG TABLET / ORAL AB Approved before 1982 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N018569-005 FUROSEMIDE 80MG TABLET / ORAL AB 1984-08-14 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N018569-001 FUROSEMIDE 40MG TABLET / ORAL AB Approved before 1982 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N018569-002 FUROSEMIDE 20MG TABLET / ORAL AB Approved before 1982 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N018569-005 FUROSEMIDE 80MG TABLET / ORAL AB 1984-08-14 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N018569-001 FUROSEMIDE 40MG TABLET / ORAL AB Approved before 1982 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N018569-002 FUROSEMIDE 20MG TABLET / ORAL AB Approved before 1982 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N018569-005 FUROSEMIDE 80MG TABLET / ORAL AB 1984-08-14 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N018569-001 FUROSEMIDE 40MG TABLET / ORAL AB Approved before 1982 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N018569-002 FUROSEMIDE 20MG TABLET / ORAL AB Approved before 1982 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N018569-005 FUROSEMIDE 80MG TABLET / ORAL AB 1984-08-14 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N018569-001 FUROSEMIDE 40MG TABLET / ORAL AB Approved before 1982 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N018569-002 FUROSEMIDE 20MG TABLET / ORAL AB Approved before 1982 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N018569-005 FUROSEMIDE 80MG TABLET / ORAL AB 1984-08-14 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N018569-001 FUROSEMIDE 40MG TABLET / ORAL AB Approved before 1982 8072bd15b7f6…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 123 observed states.
DailyMed Product Concepts# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded FUROSEMIDE ACTIVE INGREDIENT 7LXU5N7ZO5 FUROSEMIDE TABLET [SANDOZ INC] 12 FUROSEMIDE ACTIVE MOIETY 7LXU5N7ZO5 FUROSEMIDE TABLET [SANDOZ INC] 12 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X FUROSEMIDE TABLET [SANDOZ INC] 12 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 FUROSEMIDE TABLET [SANDOZ INC] 12 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ FUROSEMIDE TABLET [SANDOZ INC] 12 FUROSEMIDE ACTIVE INGREDIENT 7LXU5N7ZO5 FUROSEMIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] 2 FUROSEMIDE ACTIVE INGREDIENT 7LXU5N7ZO5 FUROSEMIDE TABLET [MCKESSON PACKAGING SERVICES BUSINESS UNIT OF MCKESSON CORPORATION] 2 FUROSEMIDE ACTIVE MOIETY 7LXU5N7ZO5 FUROSEMIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] 2 FUROSEMIDE ACTIVE MOIETY 7LXU5N7ZO5 FUROSEMIDE TABLET [MCKESSON PACKAGING SERVICES BUSINESS UNIT OF MCKESSON CORPORATION] 2 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X FUROSEMIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] 2 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X FUROSEMIDE TABLET [MCKESSON PACKAGING SERVICES BUSINESS UNIT OF MCKESSON CORPORATION] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 FUROSEMIDE TABLET [MCKESSON PACKAGING SERVICES BUSINESS UNIT OF MCKESSON CORPORATION] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 FUROSEMIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] 2 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ FUROSEMIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] 2 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ FUROSEMIDE TABLET [MCKESSON PACKAGING SERVICES BUSINESS UNIT OF MCKESSON CORPORATION] 2 FUROSEMIDE ACTIVE INGREDIENT 7LXU5N7ZO5 FUROSEMIDE TABLET [A-S MEDICATION SOLUTIONS LLC] 1 FUROSEMIDE ACTIVE MOIETY 7LXU5N7ZO5 FUROSEMIDE TABLET [A-S MEDICATION SOLUTIONS LLC] 1 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X FUROSEMIDE TABLET [A-S MEDICATION SOLUTIONS LLC] 1 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 FUROSEMIDE TABLET [A-S MEDICATION SOLUTIONS LLC] 1 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ FUROSEMIDE TABLET [A-S MEDICATION SOLUTIONS LLC] 1
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings#